Endo International

From Food & Medicine Encyclopedia

File:Endo Pharmaceuticals Logo.png

==Overview==

Endo International is a global specialty pharmaceutical company that develops, manufactures, and distributes a broad range of branded and generic pharmaceutical products. The company is headquartered in Dublin, Ireland, and has operations in various countries around the world.

History[edit]

Endo International was founded in 1997 as a result of a management buyout from DuPont Merck. The company initially focused on pain management and expanded its portfolio through strategic acquisitions and product development. Over the years, Endo has acquired several companies, including Paladin Labs, Par Pharmaceutical, and Auxilium Pharmaceuticals, to enhance its product offerings and market presence.

Business Segments[edit]

Endo International operates through several business segments:

Branded Pharmaceuticals[edit]

This segment includes the development and marketing of branded prescription products. Key therapeutic areas include pain management, urology, and endocrinology.

Sterile Injectables[edit]

Endo's sterile injectables segment focuses on the production and distribution of injectable products, including generic and branded formulations.

Generic Pharmaceuticals[edit]

The generic pharmaceuticals segment involves the development, manufacturing, and marketing of generic drugs. This segment was significantly expanded through the acquisition of Par Pharmaceutical.

Products[edit]

Endo International offers a wide range of products across various therapeutic areas. Some of the notable products include:

  • [[Opana ER - An extended-release opioid analgesic for pain management.
  • [[Xiaflex - A collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture and Peyronie's disease.
  • [[Vasostrict - A vasopressin injection used to increase blood pressure in adults with vasodilatory shock.

Controversies[edit]

Endo International has faced several controversies, particularly related to its opioid products. The company has been involved in litigation concerning the marketing and distribution of opioid medications, which have been linked to the opioid epidemic in the United States.

Related Pages[edit]


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.